Get started

LLY

Eli Lilly up and up. LLYShort term and temporarily. Immediate targets 257, 263, 272. Invalidation 232. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
NYSE:LLYLong
by Rykin_Capital
$BIIB: Update, get long!I think it warrants making a new publication here, $BIIB has flashed a buy signal with tremendously good reward to risk, as it can resume the long term trend that can take it over $1600-2600 over time. Phase 3 clinical trials have gone really well for their Alzheimer's treatment 'Aduhelm', putting it in line with results obtained by $LLY's drug 'Donanemab'. I was long $LLY and have been trading in and out of $BIIB trying to time the end of the long slide since the FDA approval news came out. I think the time is now, to get in and sit tight. I've banked my $LLY exposure, but both companies will likely do well with their Alzheimer's treatments going forward and have solid trends, but the reward to risk favors $BIIB, so I'm only long Biogen currently. Best of luck! Cheers, Ivan.
NASDAQ:BIIBLong
by IvanLabrie
Flat on Eli Lilly. LLYWe are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NYSE:LLYShort
by Rykin_Capital
LLY longEntry price: 243-245$ Target price: 283$ Stop loss: 240-243$ Bollinger Bands: The price is under the lower band. RSI: Indicator crossed the 30 level, therefore the assets is oversold. Conclusions: RSI and Bollinger Bands suggests upcoming trend reversal. However the price already crossed the 1.618 Fibonacci Retracement level, thus the entry price is recommended above that line with the stop loss under 243$ in case of continuation of the trend and retesting the new resistance level at that point. Above information should be treated in informative/education purpose, no financial advice.
NYSE:LLYLong
by vf_investment
Ely Lilly: Testing the Bear Algorithm (Entry 1)I've developed a bearish algorithm/screener that screens for stocks with identified selling pressure / trend followed by a dead cat bounce that is likely to fail - which we will attempt to short. I'm trying to combine trend following and VFI trading principles for the coming bear market. Components: 1. 200 EMA: below current market price (this is so we don't get stuck in short squeezes and such) 2. 50 day moving average above current market price (we want past clearly identified weakness over a sufficiently long period) 3. 10 day moving average below current price (we want a stock that has attempted to rally from the lows) 4. CMF<-0.1 (we want to screen out bottoming patterns such as Inverse Head and Shoulders whenever we can) 5. Moving Averages Ratings: Buy, Neutral, Sell - we don't anything with strong MA momentum indicators, and we don't want to be short squeezed. 6. Market Cap, Price, volume requirements
NYSE:LLYShort
by dtingbudong
1